ICD-10 Coding for Chronic Myelocytic Leukemia(C92.1, C92.10, C92.10B)
Comprehensive guide on ICD-10 coding for chronic myelocytic leukemia, including remission documentation and coding pitfalls.
Complete code families applicable to Chronic Myelocytic Leukemia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C92.10 | Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission | Use when CML is active and BCR/ABL-positive status is confirmed. |
|
| C92.11 | Chronic myeloid leukemia, BCR/ABL-positive, in remission | Use when CML is in remission with documented BCR/ABL1 levels. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutChronic Myelocytic Leukemia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Chronic Myelocytic Leukemia.
Omitting BCR-ABL1 levels in remission documentation
Impact
Clinical: Inaccurate assessment of disease status, Regulatory: Potential audit issues, Financial: Incorrect reimbursement for remission status
Mitigation
Regularly update lab results in patient records, Educate staff on documentation requirements
Using C92.9 when BCR/ABL status is known
Impact
Reimbursement: May lead to incorrect reimbursement rates, Compliance: Non-compliance with coding guidelines, Data Quality: Inaccurate clinical data representation
Mitigation
Confirm BCR/ABL status and use C92.1- codes accordingly.
Remission Documentation
Impact
Inadequate documentation of remission status can lead to audit failures.
Mitigation
Ensure all remission criteria are documented, including BCR-ABL1 levels.